Number of patients | 52 |
Lymph nodes with pathology | 105 |
Sex | |
Male | 39 (75%) |
Female | 13 (25%) |
Median (range) age (years) | 68 (48–80) |
Site of lung tumour | |
LUL | 9 (17%) |
LLL | 12 (23%) |
RUL | 17 (33%) |
RLL | 12 (23%) |
RML | 2 (4%) |
Primary tumour pathology obtained | 35 (67%) |
With bronchoscopy | 17 (49%) |
With transthoracic puncture (CT guided) | 5 (14%) |
With a surgical procedure | 13 (37%) |
Site of thoracic lymph nodes | |
Upper mediastinum (2–3–4–5–6) | 50 (48%) |
Subcarinal region (7) | 32 (31%) |
Lower mediastinum (8–9) | 12 (11%) |
Hilar lymph nodes (10–11) | 11 (10%) |
Lymph node pathology obtained | 50 (96%) |
With mediastinoscopy/surgery | 21 (42%) |
With EUS-FNA or EBUS-TBNA | 24 (48%) |
With EUS-FNA or EBUS-TBNA followed by surgical staging | 5 (10%) |